![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 41, 35038-35050, October 14, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶1

¶


¶¶2
From the
Departments of
Physiology and 
Pharmaceutical Sciences, **Medicine, Vascular Biology, and Genomics/Bioinformatics, Centers of Excellence, and the ¶¶ University of Tennessee Cancer Institute, University of Tennessee Health Science Center, Memphis, Tennessee 38152, the
Department of Chemistry and ¶Computational Research on Materials Institute at the University of Memphis, Memphis, Tennessee 38152, the ||Faculty of Pharmaceutical Sciences, University of Tokushima, Tokushima, 770-8505, Japan, and the 
Department of Biology, Ochanomizu University, Bunkyo-ku, Tokyo, 112 Japan
The endothelial differentiation gene family encodes three highly homologous G protein-coupled receptors for lysophosphatidic acid (LPA). Based on baculoviral overexpression studies, differences have been proposed in the structure-activity relationship (SAR) of these receptors. We have compared the SAR of the individual receptors either overexpressed transiently at high or at lower levels following stable transfection in LPA-nonresponsive RH7777 cells. The SAR in transfected RH7777 cells was markedly different from that described in insect cells. The LPA3 receptor has been proposed to be selectively activated by unsaturated LPA species and shows a strong preference for sn-2 versus the sn-1 acyl-LPA regioisomer. Because of the short half-life of sn-2 LPA due to acyl migration under some conditions, we have synthesized acyl migration-resistant analogs using an acetyl group in place of the free hydroxyl group in order to evaluate LPA receptor SAR. Only LPA1 and LPA2 showed regioisomeric preference and only for the 18:2 fatty acyl-stabilized LPA sn-1 regioisomer. To identify residues involved in ligand recognition of LPA3, we developed and validated computational models of LPA3 complexes with the analogs studied. The models revealed that Arg-3.28 and Gln-3.29 conserved within the LPA-selective endothelial differentiation gene receptors and the more variable Lys-7.35 and Arg-5.38 of LPA3 form critical interactions with the polar headgroup of LPA. The models identified Leu-2.60 and Val-7.39 of LPA3 underlying the regioisomer-selective interaction with the acetyl group of the stabilized regioisomers. Mutation of Leu-2.60 to alanine selectively increased the EC50 of the sn-2 acetyl-LPA regioisomers, whereas alanine replacement of Val-7.39 profoundly affected both regioisomers.
Received for publication, April 20, 2005 , and in revised form, August 17, 2005.
* This work was supported by United States Public Health Service Grants CA92160 and HL61469 (to G. T.) and American Heart Association Grants 50006N and 355199B (to A. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1-3.
1 Present address: Pfizer Global Research and Development Groton Laboratories, Groton, CT 06340.
2 To whom correspondence should be addressed: Dept. of Physiology, University of Tennessee Health Science Center, 894 Union Ave., Memphis, TN 38163. Tel.: 901-448-4793; Fax: 901-448-7126; E-mail: gtigyi{at}physio1.utmem.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. J. Valentine, J. I. Fells, D. H. Perygin, S. Mujahid, K. Yokoyama, Y. Fujiwara, R. Tsukahara, J. R. Van Brocklyn, A. L. Parrill, and G. Tigyi Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors J. Biol. Chem., May 2, 2008; 283(18): 12175 - 12187. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Chan, W. Peters, Y. Xu, J. Chun, R. V. Farese Jr, and S. Cases LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA) J. Leukoc. Biol., November 1, 2007; 82(5): 1193 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsuda, S. Okudaira, K. Moriya-Ito, C. Shimamoto, M. Tanaka, J. Aoki, H. Arai, K. Murakami-Murofushi, and T. Kobayashi Cyclic Phosphatidic Acid Is Produced by Autotaxin in Blood J. Biol. Chem., September 8, 2006; 281(36): 26081 - 26088. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Baker, Y. Fujiwara, K. R. Pigg, R. Tsukahara, S. Kobayashi, H. Murofushi, A. Uchiyama, K. Murakami-Murofushi, E. Koh, R. W. Bandle, et al. Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and Metastasis J. Biol. Chem., August 11, 2006; 281(32): 22786 - 22793. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsukahara, R. Tsukahara, S. Yasuda, N. Makarova, W. J. Valentine, P. Allison, H. Yuan, D. L. Baker, Z. Li, R. Bittman, et al. Different Residues Mediate Recognition of 1-O-Oleyllysophosphatidic Acid and Rosiglitazone in the Ligand Binding Domain of Peroxisome Proliferator-activated Receptor {gamma} J. Biol. Chem., February 10, 2006; 281(6): 3398 - 3407. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |